Endocrine Abstracts

Background: numerous studies using a variety of quality of life (QOL) measures have shown multiple impairments in adults with growth hormone deficiency (GHD) compared to control subjects. There have been few studies however of QOL in a treated GHD population compared with healthy controls.Method: 120 adults with treated GHD ( >1 year) were given the following QOL questionnaires at annual review: SF36, Nottingham Health Profile, Disease Impact, Life F...

OBJECTIVE: To assess the impact of untreated growth hormone deficiency (GHD) over 2 yrs in elderly patients with hypothalamic-pituitary disease. Controls were also followed for 2 yrs.SUBJECTS: 27 patients (>65 yrs) with GHD (mean) peak stimulated GH 1.6 mIU/l(range 0.6-5)were initially studied. Two yrs later 21(13 males) agreed to attend for reassessment. 27 controls (>65 y) were studied at baseline and 17 (7 males) agreed to attend for reassessmen...